Enrico Braglia

Arktis Radiation Detectors develops and manufactures next generation systems that detect and categorize radioactive and nuclear materials, contaminated cargo and other illicit materials. Founded in 2007, the company has developed proprietary advanced detection technology to create a range of products that enhance security and facilitate operations for customers and governments across the world. Arktis was the 2011 winner of the Global Security Challenge, and has since carried out work for US and UK authorities including the US Department of Homeland Security (DHS), the US Department of Defense (DoD), the UK Atomic Weapons Establishment (AWE) and the US Defense Advanced Research Projects Agency (DARPA).

HeiQ is a Swiss high-tech company that specializes in material innovations and ingredient branding for the sports, outdoor, clothing, home fabric and medical industries. Founded in 2005 as a spin-off from the Swiss Federal Institute of Technology Zurich (ETH) and listed on the London Stock Exchange Main Market (LSE:HEIQ), HeiQ is a leader in textile innovation creating some of the most effective, durable and high-performance textile technologies on the market today, which cool, warm, dry, repel, purify and stop viruses. Dedicated to improving the lives of billions of people through pioneering textiles and materials innovation, HeiQ makes every-day products more functional, more comfortable and more sustainable. Combining three areas of expertise – scientific research, specialty materials manufacturing and consumer ingredient branding – HeiQ has developed over 200 technologies in partnership with 300 major brands such as Burberry, Zara, AAPE+ by *A BATHING APE®, Burton, Mammut, Patagonia, Speedo, Dickies, Uvex, Itochu and SertaSimmons. HEIQ AT A GLANCE • Founded in 2005 during a hike in the Swiss Alps by Carlo Centonze & Dr Murray Height • Swiss Federal Institute of Technology Zurich (ETH) spin-off • More than 110 professionals of 20 nationalities in 12 countries on 5 continents • 18 major awards in 15 years • The only company that won the Swiss Technology Awards twice • Partnered with over 300 major brands worldwide • Boundless academic research network and internal development specialists • 9 patent families • Swiss headquarters with subsidiaries in Australia, China Mainland, Portugal, Taiwan and USA • Manufacturing sites on three continents HeiQ combines the flexibility and dynamism of a young and customer-oriented company with the professionalism of an international player. Engaging with you along the entire value chain, we are the ideal partner to help you innovate, differentiate your products and capture the added value at the point of sale.

APR (part of Relief Therapeutics) is a Swiss-based international biopharmaceutical company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases. APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management. A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases. Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.

Arktis Radiation Detectors develops and manufactures next generation systems that detect and categorize radioactive and nuclear materials, contaminated cargo and other illicit materials. Founded in 2007, the company has developed proprietary advanced detection technology to create a range of products that enhance security and facilitate operations for customers and governments across the world. Arktis was the 2011 winner of the Global Security Challenge, and has since carried out work for US and UK authorities including the US Department of Homeland Security (DHS), the US Department of Defense (DoD), the UK Atomic Weapons Establishment (AWE) and the US Defense Advanced Research Projects Agency (DARPA).

HeiQ is a Swiss high-tech company that specializes in material innovations and ingredient branding for the sports, outdoor, clothing, home fabric and medical industries. Founded in 2005 as a spin-off from the Swiss Federal Institute of Technology Zurich (ETH) and listed on the London Stock Exchange Main Market (LSE:HEIQ), HeiQ is a leader in textile innovation creating some of the most effective, durable and high-performance textile technologies on the market today, which cool, warm, dry, repel, purify and stop viruses. Dedicated to improving the lives of billions of people through pioneering textiles and materials innovation, HeiQ makes every-day products more functional, more comfortable and more sustainable. Combining three areas of expertise – scientific research, specialty materials manufacturing and consumer ingredient branding – HeiQ has developed over 200 technologies in partnership with 300 major brands such as Burberry, Zara, AAPE+ by *A BATHING APE®, Burton, Mammut, Patagonia, Speedo, Dickies, Uvex, Itochu and SertaSimmons. HEIQ AT A GLANCE • Founded in 2005 during a hike in the Swiss Alps by Carlo Centonze & Dr Murray Height • Swiss Federal Institute of Technology Zurich (ETH) spin-off • More than 110 professionals of 20 nationalities in 12 countries on 5 continents • 18 major awards in 15 years • The only company that won the Swiss Technology Awards twice • Partnered with over 300 major brands worldwide • Boundless academic research network and internal development specialists • 9 patent families • Swiss headquarters with subsidiaries in Australia, China Mainland, Portugal, Taiwan and USA • Manufacturing sites on three continents HeiQ combines the flexibility and dynamism of a young and customer-oriented company with the professionalism of an international player. Engaging with you along the entire value chain, we are the ideal partner to help you innovate, differentiate your products and capture the added value at the point of sale.

SeneXta Therapeutics is a biopharmaceutical company engaged in the research and development of therapies for neurodegenerative disorders including Alzheimer’s disease (AD), cognitive impairment secondary to ischemia, and other central nervous system (CNS) disorders. The company is also focused on medicines that address a large unmet medical need to maintain healthy brain ageing as well as rehabilitation after ischemic brain injury.